LRRK2 and Parkinson disease: Particularly, certain cell types in PMBCs show increased LRRK2 expression in PD patients compared to healthy controls, including B cells, T cells, CD16+ monocytes, neutrophiles, but not mixed PBMCs (Cook et al., 2017; Atashrazm et al., 2019).